Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2019, Vol. 46 Issue (5): 723-726    DOI: 10.12891/ceog4729.2019
Original Research Previous articles | Next articles
Epidemiology of hepatitis B and C in a pregnant woman in a tertiary teaching hospital in Jordan
A. Basha1, *(), Z. Amarin2, K. Haloub1, A. Kharabsheh1, O. Qudah3, I. Abu-Khader4
1Department of Obstetrics and Gynecology, The University of Jordan, Amman, Jordan
2Department of Obstetrics and Gynecology University of Science and Technology, Irbid, Jordan
3Department of Internal Medicine, The University of Jordan, Amman, Jordan
4Eastern Mediterranean Public Health Network, Amman, Jordan
Download:  PDF(319KB)  ( 200 ) Full text   ( 7 )
Export:  BibTeX | EndNote (RIS)      
Abstract  

Background: Maternal infection with hepatitis can expose the newborn to subsequent chronic hepatitis. Acquired hepatitis is a preventable condition. A low percentage of hepatitis during pregnancy was found in this study to indicate successfully adoption of the modern methods of infection control. Objective: Maternal infection with hepatitis B or C virus can expose the newborn to a subsequent chronic hepatitis infection. Perinatally acquired hepatitis B virus is a largely preventable condition. Herein, the authors aimed o determine the prevalence of hepatitis B and C virus infections among pregnant women. Materials and Methods: 48,556 pregnant women attending the delivery room between January 2005 and December 2016 were tested for hepatitis B surface antigen (HBsAg), hepatitis B antibody (HBsAb), hepatitis B e antigen (HBeAg), hepatitis B e antibody (HBeAb), hepatitis B core IgM (HBc IgM), hepatitis B core IgG (HBc IgG), and hepatitis C antibody (HCV Ab). The percentages of the above variables were determined. Results: Of the 48,556 women, 118 (0.24 %) were found to have hepatitis, 107 (0.22%) with hepatitis B, and 11 (0.02%) with hepatitis C. HBsAg was positive in 102 (86.4 %), HBsAb in six (5.1%), HBeAg in 14 (11.9%), HBeAb in 52 (44.1%), HBc IgM in seven (5.9%), HBc IgG in 51 (43.2%), and HCV Ab in 11 (9.3%). Acute hepatitis B was found in two (1.7%) women, chronic hepatitis B in 60 (50.1%), chronic hepatitis B and C in four (3.4%), chronic hepatitis C in seven (5.9%), chronic inactive hepatitis B in 39 (33.1%), latent hepatitis in two (1.7%), and resolved chronic hepatitis B in four (3.4%). Conclusions: A low percentage of seroprevalence of hepatitis B and C during pregnancy was found at a tertiary university hospital in Jordan.

Key words:  Epidemiology      Hepatitis B      Hepatitis C      Pregnancy     
Published:  10 October 2019     
*Corresponding Author(s):  A. BASHA     E-mail:  bashaasma@yahoo.com

Cite this article: 

A. Basha, Z. Amarin, K. Haloub, A. Kharabsheh, O. Qudah, I. Abu-Khader. Epidemiology of hepatitis B and C in a pregnant woman in a tertiary teaching hospital in Jordan. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(5): 723-726.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog4729.2019     OR     https://ceog.imrpress.com/EN/Y2019/V46/I5/723

[1] Mahvash Zargar, Razieh Pazhouhanfar, Mahin Najafian, Parastoo Moradi Choghakabodi. Effects of intrauterine autologous platelet-rich plasma infusions on outcomes in women with repetitive in vitro fertilization failures: a prospective randomized study[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 179-184.
[2] Saipin Pongsatha, Theera Tongsong. Intravaginal misoprostol versus sublingual misoprostol for second trimester pregnancy termination: a randomized controlled trial[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 122-127.
[3] Eman A. Elhosary, Mahmoud M. Ewidea, Marwa A. Mohamed. Efficacy of kinesio tape on neck pain and functional disability in pregnant women: a randomized controlled trial[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 175-178.
[4] Xiao-Cen Niu, Li-Hua Zhu, Zhi-Da Qian, Li-Li Huang. Disseminated intravascular coagulation developed after suction curettage in an adenomyosis patient: a case report and literature review[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 189-193.
[5] Khac Tu Chau, Minh Tam Le, Doan Tu Tran, Vu Quoc Huy Nguyen. Uterine torsion in a 25-week pregnant female with congenital uterine didelphys and intraoperative complication of uterine atony: a report of a rare clinical case[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 185-188.
[6] Iulia Baciu, Dalila-Ana Domuncu, Tiberiu Domuncu, Anca Marina Ciobanu, Theodor Voiosu, Gheorghe Peltecu, Anca Maria Panaitescu. Tenofovir disoproxil fumarate for preventing mother-to-child transmission of hepatitis B: a literature review[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 9-18.
[7] Ji Eun Park, Ji Kwon Park, Hyun Chul Jo, In Ae Cho, Jong Chul Baek. The association between antenatal corticosteroid use in late-preterm and early-term pregnancy and nonreassuring fetal status[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 79-84.
[8] Jing-Jing Jiang, Ting Han, Yan-Hui Zhu. The early second-trimester multifetal pregnancy reduction improves pregnancy outcome[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 164-167.
[9] Sureyya Saridas Demir, Erkan Cağliyan, Sabahattin Altunyurt. Retrospective analysis of pregnancy terminations and indications in a tertiary center[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 85-90.
[10] R. Mihăilă. Coagulation challenges in pregnancy: from thrombophilia involvement and management to the utility of thrombin generation monitoring[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(6): 814-820.
[11] C.W. Kim, D.H. Lee, B.S. Joo, K.S. Lee. Successful cryopreservation of mouse and human blastocysts using vitrification solution without sucrose and Ficoll[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(6): 847-855.
[12] E. Destegül, S. Gençdal, İ. Sarı, H. Akkaya, B. Çakmak, N. Gençdal. Maternal serum levels of SCUBE1 in missed abortion[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(6): 862-866.
[13] J.R. Huang, X. Li, Q.Z. Peng, J.J. Zhang, X.X. Lin, L.Q. Xie, X.H. Wu, W.S. Zhang. Elective embryo or fetal reduction for caesarean scar pregnancy combined with intrauterine pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(6): 867-874.
[14] X.R. Wang, Y.F. Wang, S.W. Kang, Y. Zhang. Treatment outcomes of uterine lesion resection versus hysterectomy for cesarean scar pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(6): 882-886.
[15] J.R. Huang, X. Li, C. Fu, Y.H. Deng, T. Gao, H.W. Zhang. Is preprocessing helpful for suction and curettage in treating cesarean scar pregnancy?[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(6): 900-905.
[1] Eli M. Roth, Michael H. Davidson. PCSK9 Inhibitors: Mechanism of Action, Efficacy, and Safety[J]. Reviews in Cardiovascular Medicine, 2018, 19(S1): 31 -46 .
[2] Sandeep K. Krishnan, Norman E. Lepor. Acute and Chronic Cardiovascular Effects of Hyperkalemia: New Insights Into Prevention and Clinical Management[J]. Reviews in Cardiovascular Medicine, 2016, 17(S1): 9 -21 .
[3] Ibrahim Sidiqi, Patrick Alexander. Current Advances in Endovascular Therapy for Infrapopliteal Artery Disease[J]. Reviews in Cardiovascular Medicine, 2015, 16(1): 36 -50 .
[4] Peter Shalit. Management of Dyslipidemia in Patients With Human Immunodeficiency Virus[J]. Reviews in Cardiovascular Medicine, 2014, 15(S1): 38 -46 .
[5] Sophie Mavrogeni, Fabrizio Cantini, Gerald M. Pohost. Systemic Vasculitis: An Underestimated Cause of Heart Failure—Assessment by Cardiovascular Magnetic Resonance[J]. Reviews in Cardiovascular Medicine, 2013, 14(1): 49 -55 .
[6] George L. Smith. Appropriate Use Criteria: The Gold Standard, or a Mechanism for the Derogation of Clinical Judgment?[J]. Reviews in Cardiovascular Medicine, 2011, 12(2): 105 .
[7] Prabhjot Singh Nijjar, Anoop Parameswaran, Aman M. Amanullah. Evaluation of Anomalous Aortic Origins of the Coronaries by 64-Slice Cardiac Computed Tomography[J]. Reviews in Cardiovascular Medicine, 2007, 8(3): 175 -181 .
[8] . SELF-ASSESSMENT POST-TEST[J]. Reviews in Cardiovascular Medicine, 2006, 7(S2): 51 -52 .
[9] Alice K. Jacobs. Gender Differences in Coronary Revascularization: Does Age Make a Difference?[J]. Reviews in Cardiovascular Medicine, 2004, 5(1): 68 -70 .
[10] Jeffrey W. Moses, Stephane Carlier, Issam Moussa. Lesion Preparation Prior to Stenting[J]. Reviews in Cardiovascular Medicine, 2004, 5(S2): 16 -21 .